SOCIAL AND PHARMACEUTICAL ASPECTS OF THE USE OF DRUGS IN SPORTS. MESSAGE 1. ANALYSIS OF WADA REQUIREMENTS AND THE LIST OF PROHIBITED SUBSTANCES

Authors

DOI:

https://doi.org/10.32782/health-2025.2.12

Keywords:

doping in sports, drug, adverse effects

Abstract

The use of various performance-enhancing substances (doping) has a major impact on athletes’ health. Issues of integrity and ethical standards in sport arise when considering the use of certain groups of substances, including medicines. The aim of our study was to study the socio-pharmaceutical aspects of the use of medicines in sports.The research materials were World Anti-Doping Agency (WADA) requirements, official international and domestic regulatory documents on anti-doping activities in sports and the official website of the National Anti-Doping Center (NADC), WADA lists of prohibited substances in 2020 and 2024, and scientific publications on the topic. The methods of a systematic approach, analysis, synthesis, comparison, and generalization were used.Ukraine fully implements current international requirements for integrity in sports, including the WADA list of prohibited substances. The organization responsible for implementing anti-doping policy in sports in Ukraine is the NADC. The impact on the human body, including side effects of substances prohibited in sports, was analyzed.An analysis of the WADA prohibited list for 2020 and 2024 showed that as of 2024, group S1 includes 74 substances (9 of which were added after 2020), S2 – 60 (7 added), S3 – 15 (2 added), S4 – 38 (2 added), S5 – 27 (3 added), S6 – 80 (6), S7 – 13 (1 added), S8 – no changes, S9 – 16 (5 added), P1 – 20 (1 added). The most significant relative quantitative changes in 2024 compared to 2020 were in group S9 – 45.5 %, also quite significant (from 12.5 % to 15.4 %) – in groups S5, S2, S1 and S3. The study of restrictions on the use of substances in sports made it possible to identify prohibited substances, summarize information about their effects and side effects on the human body, as well as the dynamics of changes in their quantity (by groups) for 2020–2024.

References

Важинський С. Е., Щербак Т. І. Методика та організація наукових досліджень : навчальний посібник. Суми : СумДПУ імені А. С. Макаренка, 2016. 260 с.

Василенко О. А., Сенча І. А. Математично-статистичні методи аналізу у прикладних дослідженнях : навчальний посібник. Одеса : ОНАЗ ім. О. С. Попова, 2011. 166 с.

Громовик Б. П., Гасюк Г. Д., Левицька О. Р. Менеджмент і маркетинг у фармації : підручник / ред. Б. П. Громовик. Київ : Медицина, 2008. 752 с.

Костенко Н. В., Іванов В. Ф. Досвід контент-аналізу: моделі та практики : монографія. Київ : Центр вільної преси, 2003. 141 с.

World Anti-doping Agency: World Anti-doping Code. 2021. URL: https://www.wada-ama.org/sites/default/files/resources/files/2021_wada_code.pdf (дата звернення: 03.03.2024).

World Anti-doping Code. International Standard. Prohibited List 2024. URL: https://www.wada-ama.org/sites/default/files/2023-09/2024list_en_final_22_september_2023.pdf (дата звернення: 03.03.2024).

Handelsman D. J. Performance Enhancing Hormone Doping in Sport. [Updated 2020 Feb 29]. In: Feingold KR, Anawalt B, Blackman MR, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc. 2000. URL: https://www.ncbi.nlm.nih.gov/books/NBK305894/ (дата звернення: 10.03.2024).

Міністерство охорони здоров’я України: У чому небезпека допінгу? URL: https://moz.gov.ua/uk/u-chomu- nebezpeka-dopingu (дата звернення: 13.03.2024).

Wenbo Z., Yan Z.. The Uses of Anabolic Androgenic Steroids Among Athletes; Its Positive and Negative Aspects – A Literature Review. J Multidiscip Healthc. 2023 Dec 29;16:4293-4305. doi: 10.2147/JMDH.S439384

Patanè F. G., Liberto A., Maglitto A. N. M., Malandrino P., Esposito M., Amico F., Cocimano G., Li Rosi G., Condorelli D., Di Nunno N., et al. Nandrolone Decanoate: Use, Abuse and Side Effects. Medicina. 2020; 56: 606. doi: 10.3390/medicina56110606

Albano G. D., Amico F., Cocimano G., Liberto A., Maglietta F., Esposito M., Rosi G. L., Di Nunno N., Salerno M., Montana A. Adverse Effects of Anabolic-Androgenic Steroids: A Literature Review. Healthcare (Basel). 2021 Jan 19;9(1):97. doi: 10.3390/healthcare9010097

Handelsman D. J. Performance Enhancing Hormone Doping in Sport. [Updated 2020 Feb 29]. In: Feingold KR, Anawalt B, Blackman MR, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000. URL: https://www.ncbi.nlm.nih.gov/sites/books/NBK305894/(дата звернення: 13.03.2024)

Zhu Yu., Song G. Molecular origin and biological effects of exercise mimetics. Journal of Exercise Science and Fitness. (vol. 22, issue 1) 2024. 73–85. https://doi.org/10.1016/j.jesf.2023.12.002

Elmeligie M. M. Exercise Mimetics: An Emerging and Controversial Topic in Sport and Exercise Physiology. 2021. doi: http://dx.doi.org/10.5772/intechopen.102533

Jaipal. Beta 2 Agonist: Therapeutic Use Exemption, Misuse in Sports and its Adverse Effect on Health. International Journal of Science and Research (IJSR). (vol. 2, issue 12). December 2013. 220–223. URL: https://www.ijsr.net/archive/v2i12/MDIwMTM1ODY=.pdf. (дата звернення: 11.03.2024).

Vertadier N., Trzepizur W., Faure S. Overuse of Short-Acting Beta-2 Agonists (SABAs) in Elite Athletes: Hypotheses to Explain It. Sports 2022, 10(3), 36; https://doi.org/10.3390/sports10030036

Jaipal (2013). Legal and illegal use of insulin in sports and its advrse effects on health. Internat. J. Phy. Edu., 6(2) : 98–101. URL: http://researchjournal.co.in/upload/assignments/6_98-101.pdf (дата звернення: 15.03.2024).

Eichner A., Lewis L. A., Leonard B., Wagoner R. M. V., Eichner D., Fedoruk M. N. (2021). Generic Pharmaceuticals as a Source of Diuretic Contamination in Athletes Subject to Sport Drug Testing. Front. Sports Act. Living 3:692244. doi: 10.3389/fspor.2021.692244

WADA: Stakeholder Notice regarding potential diuretic contamination cases. 1 June 2021. URL: https://www.wada-ama.org/sites/default/files/resources/files/stakeholder_notice_regarding_contamination_with_certain_diuretics_final_1_june_2021.pdf (дата звернення: 10.03.2024).

Arumugham V. B., Shahin M. H. Therapeutic Uses of Diuretic Agents. [Updated 2023 May 29]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan. URL: https://www.ncbi.nlm.nih.gov/books/NBK557838/ (дата звернення: 13.03.2024).

Berezanskaya J., Cade W., Best T. M., Paultre K., Kienstra C. ADHD Prescription Medications and Their Effect on Athletic Performance: A Systematic Review and Meta-analysis. Sports Med Open. 2022 Jan 13;8(1):5. doi: 10.1186/ s40798-021-00374-y

Kamal M., Eltohami M., Al-Shibli S., Khan S., Al-Kuwari, et al. (2018) Effect and Side Effect of Stimulant/Methylphenidate on Children and Adolescents with ADHD: The Qatar Experience. Arch Pediatr 3: 160. DOI: 10.29011/2575-825X.100060

Nanda A., Janga L. S. N., Sambe H. G., Yasir M., Man R. K., Gogikar A., Mohammed L. Adverse Effects of Stimulant Interventions for Attention Deficit Hyperactivity Disorder (ADHD): A Comprehensive Systematic Review. Cureus. 2023 Sep 26; 15(9):e45995. doi: 10.7759/cureus.45995

Burr J., Cheung Ch., Kasper A., Gillham S., Close G. (2021). Cannabis And Athletic Performance. Sports Medicine. doi: 10.1007/s40279-021-01505-x

Vernec A., Slack A., Harcourt P., Budgett R., Duclos M., Kinahan A., Mjøsund K., Strasburger Ch. (2019). Glucocorticoids in elite sport: current status, controversies and innovative management strategies – a narrative review. British Journal of Sports Medicine. 54. bjsports-2018. doi: 10.1136/bjsports-2018-100196

Riiser A, Stensrud T, Andersen LB. Glucocorticoids and physical performance: A systematic review with meta-analysis of randomized controlled trials. Front Sports Act Living. 2023 Mar 23;5:1108062. doi: 10.3389/fspor.2023.1108062

Oray M., Abusamra K., Ebrahimiadib N., Meese H., Foster, C. (2016). Long-term side effects of glucocorticoids. Expert opinion on drug safety. 15. doi: 10.1517/14740338.2016.1140743

Hanania N. A., Chapman K. R., Kesten S. Adverse effects of inhaled corticosteroids. Am J Med. 1995 Feb; 98(2):196–208. doi: 10.1016/S0002-9343(99)80404-5

Beta blockers. In L. J. Micheli (Ed.) Encyclopedia of sports medicine. 2011. (Vol. 4, pp. 150–150). SAGE Publications, Inc. https://doi.org/10.4135/9781412961165

Blanco J. L. T. Doping in sport and cardiovascular risk. Arch Med Deporte 2022;39(6):302–305. doi: 10.18176/archmeddeporte.00107

World anti-doping code international standard. Prohibited list 2020. URL: https://www.wada-ama.org/sites/default/files/wada_2020_english_prohibited_list_0.pdf (дата звернення: 12.03.2024).

Published

2025-06-30

Issue

Section

PHARMACY